Dr. Philip Just Larsen

Member of the Corporate Executive Board, Chief Scientific Officer

Philip Just Larsen is an entrepreneurial researcher who has experienced the pharmaceutical industry from many different angles. An MD trained in internal medicine and neurology, he founded and led the biopharmaceutical company Rheoscience A/S, and held senior management roles in various stock market listed companies, including the role of Chief Scientific Officer at Sanofi’s German Hub in Frankfurt. Philip joined Grünenthal as Chief Scientific Officer and Member of the Corporate Executive Board in July 2018.

He is convinced that “with our scientific curiosity, the specific expertise in pain, in-house capabilities for all stages of drug development, and the shared motivation to serve patients in need, Grünenthal has everything that is needed to take pain management to the next level.”

Dr. Philip Just Larsen at a glance

Nationality: Danish

Year of birth: 1962

Education: Ph.D. in Neuroscience/Endocrinology, University of Copenhagen

Family status: Married, two children

Career highlights

Since 07/2018: Chief Scientific Officer and Member of the Corporate Executive Board, Grünenthal

01/2016 – 06/2018: Chief Scientific Officer German Hub, Sanofi

08/2012 – 06/2018: : Global Head of Diabetes Research and Translational Science, Sanofi

10/2008 – 04/2011: : CSO Diabetes Research, Lilly

External Link:
You are now leaving the Grünenthal (IE) website. You will be re-directed to an external website. Grünenthal Pharma Ltd., Ireland accepts no responsibility for the content of other websites. ... Cancel ... Ok